Context Therapeutics Inc. — Director's Dealing 2021

Oct 20, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-19

Reporting Person: Rencher William F. (Head of CMC and Regulatory)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1666	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$16.92	2030-04-02	Common Stock (12333)		Direct

Footnotes

F1: The stock option vests in full 24 months from the date of the grant, April 2, 2020.